Insmed (INSM) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.27 -0.6%
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.80), $0.09 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $58.79 million.
As of June 30, 2022, Insmed had cash and cash equivalents and marketable securities of $564.6 million. The Company\'s total operating expenses for the second quarter of 2022 were $153.5 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Mizuho on Insmed (INSM): 'seeing attractive risk/reward'
- KT&G approves KRW 360 billion share buyback and retirement plan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
